Sharesmagazine
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Share Price   Awards   Market Scan   Videos   Broker Notes   Director Deals   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Indices   Forward Diary   Forex Prices   Shares Magazine   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Comparison Tables   Spread Betting 
You are NOT currently logged in
 
Register now or login to post to this thread.

Provexis Buy at 3.25p - Target 8p (PXS)     

peeyam - 08 May 2007 11:30

LONDON (AFX) - Provexis PLC said it has entered into a long-term collaboration agreement with Unilever PLC to jointly develop a new concentrated format of its patented Fruitflow heart-health technology for application in Unilever's food product portfolio.

Financial details of the deal were not disclosed.

The partners plan to enter into a global licence arrangement for the technology.

Fruitflow is a patented natural extract from tomato which Provexis said has been shown in human trials to reduce the propensity for aberrant blood clotting that is typically associated with cardiovascular disease and which can lead to heart attack or stroke.

In 2005 the market for heart benefit foods was worth 4 bln usd globally, Provexis added.

Considering the growth potential this share has a target of about 8-10p in the medium tern and is a good buy at current levels

As usual, pls do ur own research.

peeyam - 11 Jul 2007 10:56 - 27 of 1204

Big news, change in directorship, New director from rubicon group, with experience in mergers and aquisitions.

skyhigh - 11 Jul 2007 11:13 - 28 of 1204

PXS mean business then...

peeyam - 13 Jul 2007 08:36 - 29 of 1204

with yerterdays selling i guess short timers and some profit takers are out so hope we can march ahead again. 8p fingers crossed

peeyam - 28 Aug 2007 12:14 - 30 of 1204

3.75p to buy following recent market fall, good level to buy now

outlook123 - 08 Sep 2007 17:18 - 31 of 1204

Chat on iii board suggests that an announcement is due by the end of this month.

Also, tipped in "Shares" magazine this week:-

http://www.sharesmagazine.com/node/1227

peeyam - 14 Sep 2007 10:43 - 32 of 1204

SAS Rue la Boetie
Credit Agricole SA
Calyon SA
Credit Agricole Cheuvreux SA 15,000,000 3.74%

Global Nomad - 25 Sep 2007 00:26 - 33 of 1204

it's clear that there is not much interest here for this share. I guess when news eventually arrives there will be a rush of interest lol, good 17% rise today and expectations rather than fact. Too many people have bene very patient with this one but it will come good.

Toya - 25 Sep 2007 07:55 - 34 of 1204

Hi Global Nomad - I've been watching this one, too, and was pleased to see the shift yesterday. I'm convinced that contracts for Fruitflow will flow eventually, so am holding on to my shares.

outlook123 - 10 Oct 2007 22:13 - 35 of 1204

Large volume today.

Announcement believed to be imminent.

skyhigh - 11 Oct 2007 07:32 - 36 of 1204

I'll believe it when I see it !

I'll continue to hold but it's very tedious waiting around for the "good news"

Toya - 11 Oct 2007 07:55 - 37 of 1204

I've been hanging around for ages on this one, and in the end sold as I got bored. However, today's Press Roundup has this from The Times: "Word of a tie-up between Provexis and Coca-Cola".

I think it's time to buy some again, while it's still quiet out there.

skyhigh - 11 Oct 2007 08:09 - 38 of 1204

Yes, this from the Times this am... it all sounds rather laboured and drawn out and is based on evaluations at this stage..but... it's better than nothing !

AIM-listed Provexis, the developer of functional foods, held steady at 4.125p, despite word of a tie-up with Coca-Cola. The company is expected to confirm that the Atlanta-based soft drinks giant is evaluating the potential use of Fruitflow, Provexiss patented tomato extract, which it claims helps to thin the blood. Unilever is currently assessing the use of Fruitflow in dairy products.

Toya - 11 Oct 2007 08:27 - 39 of 1204

Thanks Skyhigh - I'd not seen the details. I'm sure we'll get there eventually - have bought some this morning but didn't have a lot of spare cash as it's tied up elsewhere, waiting for profits...

outlook123 - 11 Oct 2007 20:27 - 40 of 1204


From "Shares" magazine today:-

Provexis bears fruit
PXS
Published date:Thursday, October 11, 2007
Last month we reported that Provexis (PXS:AIM) was in discussions with both Coca-Cola (KO:NYSE) and PepsiCo (PEP:NYSE) about the possibility of licensing its Fruitflow technology to the drinks makers (Shares 6 September). As we go to press we understand that an announcement is imminent, probably this week.

The groups technology is designed to reduce the risk of heart disease and it is already being used under licence by Unilver (ULVR). Acceptance by one of the US drinks giants will certainly act as a further fillip for the shares, which have already risen 14% in the last month to 4.1p. In the longer term the Fruitflow technology could have further applications such as lowering the chances of deep-vein thrombosis (DVT), which would again be a significant market.

Shares says: At last the patience of shareholder is being rewarded. JM

SPECULATIVE BUY

Global Nomad - 11 Oct 2007 20:36 - 41 of 1204

missed 'last months report' entirely, did anyone actually see it/read it?

no move on price today seems odd, given the Times report and this article......

outlook123 - 11 Oct 2007 21:00 - 42 of 1204

outlook123 - 08 Sep 2007 17:18 - 31 of 41

Chat on iii board suggests that an announcement is due by the end of this month.

Also, tipped in "Shares" magazine this week:-

http://www.sharesmagazine.com/node/1227

Toya - 12 Oct 2007 08:35 - 43 of 1204

Thanks for that info in 40 above, Outlook123 . Can't be long now!

Toya - 14 Nov 2007 07:15 - 44 of 1204

RNS today:
Provexis PLC
14 November 2007

Provexis and Unilever renew Fruitflow(R) Exclusivity Agreement
Provexis, developer of scientifically-proven functional food, dietary supplement
and medical food technologies, announces that it has progressed its exclusivity
agreement with Unilever plc on to look specifically at how Provexis might
develop a new format of its patented Fruitflow(R) heart-health technology for
potential application in Unilever's spread product portfolio.

Fruitflow(R) is a patented natural extract from tomato which has been shown in
human trials to reduce the propensity for aberrant blood clotting, typically
associated with cardiovascular disease, which can lead to heart attack or
stroke. Unilever has substantial global brands in the heart-health market,
primarily its Flora/Becel spreads and drinking yoghurts, which have sales in
excess of 1bn.

The partners have successfully developed a pilot-scale version of the new
concentrated format over the past year, which subsequently showed positive
results in a recent human trial. Under the terms of new agreement, which extends
for 12 months, Provexis will now further develop this new technology to deliver
a product suitable for potential incorporation into vegetable-oil based fat
spreads. Unilever will transfer certain manufacturing assets to Provexis to
facilitate this phase of the project.

There are four sectors in which Provexis is seeking major partnerships, namely,
food and dairy, beverages, products for deep vein thrombosis, and dietary
supplements and medical products.

Commenting on the renewal of the collaboration agreement, Stephen Moon, CEO of
Provexis, said: 'We are pleased with the progress made over the last year and
are now focusing on delivering this important new format in a product suitable
for Unilever's spread range.'

outlook123 - 15 Nov 2007 16:06 - 45 of 1204

http://www.foodnavigator.com/news/ng.asp?n=81375-unilever-provexis-fruitflow-spreads

Toya - 15 Nov 2007 20:14 - 46 of 1204

Interesting article - many thanks for the link, Outlook.
Register now or login to post to this thread.